Globenewswire·2025-12-09 16:07Core Viewpoint - Holzer & Holzer, LLC is reminding investors of deadlines to seek lead plaintiff status in several class action lawsuits against companies including MoonLake Immunotherapeutics, DexCom, and Synopsys, alleging misleading statements and failure to disclose material facts during specified periods [1][2][3]. Group 1: MoonLake Immunotherapeutics (MLTX) - A class action lawsuit has been filed against MoonLake Immunotherapeutics, alleging that the company made materially false and/or misleading statements regarding SLK's superiority to monoclonal antibodies between March 10, 2024, and September 29, 2025 [1]. - Investors who purchased shares during this period and suffered significant losses are encouraged to discuss their legal rights [1]. Group 2: DexCom, Inc. (DXCM) - A class action lawsuit has been filed against DexCom, alleging that the company made materially false and/or misleading statements regarding design changes to its G6 and G7 products between January 8, 2024, and September 17, 2025 [2]. - Investors who purchased shares during this period and suffered significant losses are encouraged to discuss their legal rights [2]. Group 3: Synopsys, Inc. (SNPS) - A class action lawsuit has been filed against Synopsys, alleging that the company made materially false and/or misleading statements regarding the economics of its Design IP business between December 4, 2024, and September 9, 2025 [3]. - Investors who purchased shares during this period and suffered significant losses are encouraged to discuss their legal rights [3]. Group 4: Holzer & Holzer, LLC - Holzer & Holzer, LLC is recognized as a top-rated securities litigation law firm and has been involved in recovering hundreds of millions of dollars for shareholders affected by fraud and corporate misconduct since its founding in 2000 [4]. - The firm is dedicated to representing shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation [4].